Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-08T12:40:55.107Z Has data issue: false hasContentIssue false
  • English
  • Français

Obsessions, Compulsions, Clozapine, and Risperidone

Published online by Cambridge University Press:  07 November 2014

Robert W. Baker ,
Paul D. Bermanzdhn ,
Donna Ames Wirshing  and
K. N. Roy Dhengappa
Get access Rights & Permissions [Opens in a new window]

Extract

In the past decade, clozapine, risperidone, and olanzapine were marketed for the first time in the United States, and other new antipsychotic drugs are expected to follow soon. Also within the past decade, the efficacy of serotonin-reuptake inhibitors (SRIs) has been demonstrated in patients with obsessive-compulsive disorder (OCD) and the serotonin hypothesis of OCD has been articulated clearly.

Information

Type
Feature Articles
Information
CNS Spectrums , Volume 2 , Issue 3: Schizophrenia & OCD: Convergence , March 1997 , pp. 26 - 36
Copyright
Copyright © Cambridge University Press 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1.Barr, LC, Goodman, WK, Price, LH. The serotonin hypothesis of obsessive compulsive disorder. International Clinical Psychopharmacology. 1993;8(suppl 2):79-82Google Scholar
2.Insel, TR, Akiskal, HS. Obsessive-compulsive disorder with psychotic features: a phenomenologic analysis. Am J Psychiatry. 1986;143:1527-1533.Google Scholar
3.Eisen, JL, Rasmussen, SA. Obsessive-compulsive disorder with psychotic features. J Clin Psychiatry. 1993;54:373-379.Google Scholar
4.Kozak, MJ, Foa, EB. Obsessions, overvalued ideas, and delusions in obsessive-compulsive disorder. Behav Res Ther. 1994;32:343-353.CrossRefGoogle ScholarPubMed
5.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.Google Scholar
6.Rosen, I.The clinical significance of obsessions in schizophrenia. JMentSci. 1957;103:773-785.Google ScholarPubMed
7.Fenton, WS, McGlashan, TH.The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986;143:437-441.Google Scholar
8.Berman, I, Kalinowski, A, Berman, SM, Lengua, J, Green, Al. Obsessive and compulsive symptoms in chronic schizophrenia. Comprehensive Psychiatry. 1995;36:6-10.Google Scholar
9.Eisen, JL, Beer, DA, Pato, MT, Venditto, TA, Rasmussen, SA.Obsessive-compulsive disorder in patients with schizophrenia or schizoaffective disorder. Am J Psychiatry. 1997;154:271-273.Google Scholar
10.Goodman, WK, Price, LH, Rasmussen, SA, et al. The Yale-Brown Obsessive Compulsive Scale: I. development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006-1011.Google Scholar
11.Goodman, WK, Price, LH, Rasmussen, SA, et al. The Yale-Brown Obsessive Compulsive Scale: II. validity. Arch Gen Psychiatry. 1989;46:1012-1016.Google Scholar
12.Petty, F, Davis, LL, Kabel, D, Kramer, GL. Serotonin dysfunction disorders: a behavioral neurochemistry perspective. J Clin Psychiatry. 1996;57(suppl 8):11-16.Google ScholarPubMed
13.Rapoport, JL. The biology of obsessions and compulsions. Scientific American. March 1989; 83-89.Google Scholar
14.Trivedi, MH. Functional neuroanatomy of obsessive-compulsive disorder. J Clin Psychiatry. 1996;57(suppl 8):26-35.Google Scholar
15.Grove, G, Coplan, J, Margolin, L, Hollander, E. The neuroanatomy of serotonin (5-HT) dysregulation in obsessivecompulsive disorder. CNS Spectrums. 1996;1:16-22.Google Scholar
16.Abi-Dargham, A, Laruelle, M, Aghajanian, GK, Charney, D, Krystal, J. The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiatry Clin Neuwsciences. 1997;9:1-17.Google Scholar
17.Ghaemi, SN, Zarate, CA, Popli, AP, Pillay, SS, Cole, JO. Is there a relationship between clozapine and obsessive-compulsive disorder? a retrospective chart review. Comprehensive Psychiatry. 1995;36:267-270.Google Scholar
18.Remington, G, Adams, M. Risperidone and obsessive-compulsive symptoms. J Clin Psychopharmacol. 1994;14:358- 359.CrossRefGoogle ScholarPubMed
19.Wirshing, DA, Ross, S, Wirshing, WC, Sun, AB. Schizophrenia, obsessive compulsive disorder, and tremor, Publication pending.Google Scholar
20.Toren, P, Samuel, E, Weizman, R, Golomb, A, Eldar, S, Laor, N. Emergence of transient compulsive symptoms during treatment with clothiapine. J Am Acad Child Adolesc Psychiatry. 1995;34:1469-1472.Google Scholar
21.Leysen, JE, Janssen, PMF, Schotte, A, Luyten, WHML, Megens, AAHP. Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clincal effects: role of 5-HT2 receptors. Psychopharmacology. 1993;112:S40-S54.Google Scholar
22.Allen, RM. Risperidone and obsessive-compulsive disorder. Psychiatric Annals. 1995;25:523-524.Google Scholar
23.Mozes, T, Toren, P, Chernauzan, N, et al. Clozapine treatment in very early onset schizophrenia. J Am Acad Child Adolesc Psychiatry. 1994;33:65-70.Google Scholar
24.Buckely, PF, Sajatovic, M, Meltzer, HY. Treatment of delusional disorders with clozapine. Am J Psychiatry. 1994;151:1394-1395.Google Scholar
25.Baker, RW, Ames, D, Umbricht, DSG, Chengappa, KNR, Schooler, NR. Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo. Psychopharmacol Bull. 1996;32:89-93.Google Scholar
26.Levin, Z, Hwang, MY, Rotrosen, J. Correspondence. Comprehensive Psychiatry (letter). 1995;37:74.Google Scholar
27.Ames, D, Wirshing, WC, Marshall, BD, et al. Risperidone vs haloperidol in treatment resistant schizophrenia. Presented at the Annual Meeting of the American College of Neuropharmacology; Dec. 9-13, 1996; San Juan, Puerto Rico.Google Scholar
28.Howland, RH. Chlorpromazine and obsessive-compulsive symptoms. Am J Psychiatry. 1996; 153:1503.Google ScholarPubMed
29.Vitiello, B, Spreat, S, Behar, D. Obsessive-compulsive disorder in mentally retarded patients. J New Ment Dis. 1989;177:232-235.Google Scholar
30.Yaruba-Tobias, JA, Neziroglu, MA, Bergman, L. Clomipramine for obsessive-compulsive neurosis: an organic approach. Curr Ther Res. 1976;20:541-548.Google Scholar
31.Pulman, J, Yassa, R, Ananth, J. Clomipramine treatment of repetitive behavior. Can J Psych. 1984;29:254-255.Google Scholar
32.Stroebel, CF, Szarek, BL, Glueck, BC. Use of clomipramine in treatment of obsessive compulsive symptomatology. J CM Psyche-pharmacology. 1984;4:98-100.Google Scholar
33.Zohar, J, Kaplan, Z, Benjamin, J. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. J Clin Psychiatry. 1993;54:385-388.Google ScholarPubMed
34.Hwang, MY, Martin, AM, Lindemayer, JP, Stein, D, Hollander, E. Treatment of schizophrenia with obsessive-compulsive features with serotonin reuptake inhibitors. Am J Psychiatry. 1993;150:1127.Google Scholar
35.Berman, l, Sapers, BL, Chang, HHJ, Losonczy, MF, Schmidler, J, Green, Al. Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine. J Clin Psychopharmacol. 1995;15:206-210.Google Scholar
36.Eales, MJ, Layeni, AO. Exacerbation of obsessive-compulsive symptoms associated with clozapine. Br J Psychiatry. 1994;164:687-688.Google Scholar
37.Patil, VJ. Development of transient obsessive-compulsive symptoms during treatment with clozapine. Am J Psychiatry. 1992;149:272.Google Scholar
38.Levkovich, Y, Kronnenberg, Y, Gaoni, B. Can clozapine trigger OCD? JAm Acad Child Adolesc Psychiatry. 1995;34:263.Google Scholar
39.Patel, B, Tandon, R. Development of obsessive-compulsive symptoms during clozapine treatment. Am J Psychiatry. 1993;150:836.Google Scholar
40.Steingard, S, Chengappa, KNR, Baker, RW, Schooler, NR. Clozapine, obsessive symptoms and serotonergic mechanisms. Am J Psychiatry. 1993;150:1435.Google Scholar
41.Allen, L, Tejera, C. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline. Am J Psychiatry. 1994;151:1096-1097.Google Scholar
42.Cassady, SL, Thaker, GK. Addition of fluoxetine to clozapine. Am J Psychiatry. 1992;149:1274.Google ScholarPubMed
43.Kopala, L, Honer, WG. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1994;151:1714-1715.Google Scholar
44.Alzaid, K, Jones, BD. A case of risperidone-induced obsessive-compulsive symptoms. J Clin Psychopharmacol. 1997;17:58-59.Google Scholar
45.McDougle, CJ, Fleischmann, RL, Epperson, CN, Wasylink, S, Leckman, JF, Price, LH. Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases. J Clin Psychiatry. 1995;56:526-528.Google Scholar
46.Delgado, PL, Goodman, WK, Price, LH, Heninger, GR, Charney, DS. Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder. Brit J Psychiatry. 1990;157:762-765.Google Scholar
47.McDougle, CJ, Goodman, WK, Price, LH, et al. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry. 1990;147:652-654.Google Scholar
48.McDougle, CJ, Goodman, WK, Leckman, JF, Lee, NC, Heninger, GR, Price, LH. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A doubleblind placebo-controlled study in patients with and without tics. Arch Gen Psychiatry. 1994;51:302-308.Google Scholar
49.Young, CR, Bostic, JO, McDanald, CL. Clozapine and refractory obsessive-compulsive disorder: a case report. J Clin Psychopharmacol. 1994;14:209-211.Google Scholar
50.LaPorta, LD. More on obsessive-compulsive symptoms and clozapine. J Clin Psychiatry. 1994;55:312.Google Scholar
51.Baker, RW, Chengappa, KNR, Steingard, S, Schooler, NR, Baird, JW. More on obsessive-compulsive symptoms and clozapine: reply to Laporta, LD. J Clin Psychiatry. 1994;55: 312. Letter.Google Scholar
52.Fuchs, DC. Clozapine treatment of bipolar disorder in a young adolescent. J Am Acad Child Adolesc Psychiatry. 1994;33:1299-1302.Google Scholar
53.McDougle, CJ, Barr, LC, Goodman, WK, et al. Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder. Am J Psychiatry. 1995;152:1812-1814.Google Scholar
54.Giakas, WJ. Risperidone treatment for a Tourette's disorder patient with comorbid obsessive-compulsive disorder. Am J Psychiatry. 1995; 152:1097-1098.Google Scholar
55.Jacobsen, FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry. 1995;56:423-429.Google ScholarPubMed
56.Saxena, S, Wang, D, Bystritsky, A, Baxter, LR. Risperidone augmentation of SRI treatment for refractory obsessivecompulsive disorder. J Clin Psychiatry. 1996;57:303-306.Google Scholar
57.Baker, RW, Chengappa, KNR, Baird, JW, Steingard, S, Christ, MAG, Schooler, NR.Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry 1992;53:439-442.Google Scholar
58.Dursun, SM, Reveley, MA. Obsessive-compulsive symptoms and clozapine. Brit J Psychiatry. 1994; 165:267-268.Google Scholar
59.Goodman, WK, McDougle, CJ, Price, LH, Riddle, MA, Pauls, DL, Leckman, JF. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive-compulsive disorder? J Clin Psychiatry 1990:51 (suppl 8):36-43.Google Scholar
60.Kindler, S, Kaplan, Z, Zohar, J. Obsessive-compulsive symptoms in schizophrenia. In: Hollander E, ed. Obsessive-Compulsive-Related Disorders. Washington, DC: American Psychiatric Press, Inc; 1993:203-214.Google Scholar
61.Centorrino, F, Baldessarini, RJ, Frankenburg, FR, Kando, J, Volpicelli, SA, Flood, JG. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. Am J Psychiatry. 1996;153:820-822.Google Scholar
62.Goff, DG, Midha, KK, Brotman, AW, Waites, M, Baldessarini, RJ. Elevation of plasma concentrations of haloperidol after the addition of fluoxetine. Am J Psychiatry. 1991;148:790-792.Google Scholar